Dr Gian P. Camenisch, Novartis Institute of Biomedical Research (NIBR), Basel 2018-11-21 17:00:00

Back to Events

Date:
Start:Wednesday, 21 November 2018Time:17:00
End:Wednesday, 21 November 2018Time:18:00
Category: Uni Basel, Pharmazeutische Wissenschaften
Description:

Assessing Class-Dependant Drug fugiat Development Risk using labore a novel Compound fugiat Categorization
Approach.

Venue: Lecture Hall 1, Pharmazentrum
Klingelbergstrasse 50, 4056, Basel
Country:Switzerland
Lecture CycleSeminars on Drug Sciences (SDS)
Email: Send
Website: https://pharma.unibas.ch/de/teaching/sds/
Event Type
This event is public. Anyone can attend and invite others to attend.
Admins
Manuela Rogalski (creator)

TPL_BEEZ2_ADDITIONAL_INFORMATION